Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessing the Impact and Complications of Cytomegalovirus (CMV) Reactivation in a Multi-site Study of Allogeneic Haematopoietic Stem Cell Transplant Recipient

NCT03806764 is registered in ClinicalTrials.gov with Melbourne Health as lead sponsor.

NCT NCT03806764
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03806764 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessing the Impact and Complications of Cytomegalovirus (CMV) Reactivation in a Multi-site Study of Allogeneic Haematopoietic Stem Cell Transplant Recipient
Lead sponsor
Melbourne Health
Phase
Not applicable
Overall status
Unknown status
Start date
April 17, 2018
Completion date
December 31, 2023
Enrollment
370 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cytomegalovirus infections, haematological malignancy, immune suppression, organ or tissue transplant; complications